NCT05920343: VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 120 planned
- Started
- 4 Nov 2024
- Primary completion
- Jun 2028
- Arms
- Rivaroxaban
- Results
- None posted
- 27 Jun 2023: Trial registered
- 4 Nov 2024: Trial started